bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Aclaris Therapeutics Inc. logo

    Aclaris Therapeutics Inc.

    ACRS | NASDAQ
    Chart Builder DCF Calculator
    $5.65
    +$0.08 (+1.44%)
    Sep 22, 2026, 2:47 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $777.93M
    Enterprise Value
    $686.37M
    Beta
    0.80
    Average Volume
    1.7M
    Shares Outstanding (Diluted)
    142.74M
    Shares Change YoY
    16.44%
    Institutional Ownership
    84.40%
    Exchange
    NASDAQ
    ISIN
    US00461U1051

    Price Performance

    Price Change 1M
    -12.3%
    Price Change 3M
    13.2%
    Price Change 6M
    55.1%
    Price Change YTD
    93.4%
    Price Change 1Y
    188.6%
    Price Change 3Y
    -16.2%
    Price Change 5Y
    -69.2%
    1M CAGR (ann.)
    -5.8%
    1Y CAGR (ann.)
    185.6%
    5Y CAGR (ann.)
    -20.7%
    All-Time CAGR
    -6.0%

    Valuation

    PE Ratio
    -9.60
    Forward PE
    N/A
    PEG Ratio
    -0.21
    Forward PEG
    -0.75
    PS Ratio
    94.65
    Forward PS
    134.80
    PB Ratio
    6.24
    P/FCF Ratio
    -12.51
    P/Adj. FCF Ratio
    -10.54
    P/OCF Ratio
    -12.95
    EV/Sales
    83.51
    EV/EBIT
    -9.06
    EV/EBITDA
    -9.14
    EV/FCF
    -11.04
    Earnings Yield
    -10.4%
    FCF Yield
    -8.0%
    Adj. FCF Yield
    -9.5%

    Financial Health

    Net Cash
    $91.56M
    Total Debt
    $0
    Cash & Short-Term Investments
    $91.56M
    Total Assets
    $179.69M
    Current Ratio
    3.46
    Quick Ratio
    3.46
    Debt / Equity Ratio
    0.00
    Debt / EBITDA
    -0.00
    Debt / FCF
    -0.00
    OCF / Debt
    N/A
    Interest Coverage
    0.00
    Altman Z-Score
    -0.27
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    95.6%
    Operating Profit Margin
    -1050.2%
    EBITDA Margin
    -913.9%
    Net Profit Margin
    -921.5%
    FCF Margin
    -756.5%
    Adj. FCF Margin
    -898.3%
    SBC / Revenue
    141.8%
    SBC Impact (per share)
    -18.8%

    Returns

    Return on Assets
    -42.1%
    Return on Equity
    -61.6%
    Return on Invested Capital
    -57.0%
    Return on Capital Employed
    -57.0%
    Return on Tangible Assets
    -42.1%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -35.9%
    Revenue CAGR 5Y
    4.4%
    Revenue CAGR 10Y
    14.2%
    EPS CAGR 3Y
    13.0%
    EPS CAGR 5Y
    14.2%
    EPS CAGR 10Y
    14.7%
    FCF CAGR 3Y
    2.5%
    FCF CAGR 5Y
    6.6%
    FCF CAGR 10Y
    1.8%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    16
    EPS Growth Next 3Y
    -15.5%
    Revenue Growth Next 3Y
    45.6%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$0.17
    EPS Growth Est (next Q)
    41.7%
    Revenue Est (next Q)
    $1.3M
    Revenue Growth Est (next Q)
    -60.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $10.60
    Price Target Upside
    90.3%

    Cash Flow

    Operating Cash Flow
    $-62.06M
    Free Cash Flow
    $-62.18M
    Adj. Free Cash Flow
    $-73.83M
    FCF Per Share
    -$0.44
    OCF Per Share
    -$0.43
    OCF/S Ratio
    -755.1%

    Income Statement

    Revenue
    $8.22M
    Gross Profit
    $7.86M
    Operating Income
    $-86.31M
    EBITDA
    $-75.12M
    Net Income
    $-75.74M
    EPS (Diluted)
    -$0.58
    Revenue / Employee
    $115.76K
    Profit / Employee
    $-1.07M
    Employees
    71

    © 2026 bestshares.com. All rights reserved.